These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36705810)

  • 1. Artificial intelligence-based digital scores of stromal tumour-infiltrating lymphocytes and tumour-associated stroma predict disease-specific survival in triple-negative breast cancer.
    Albusayli R; Graham JD; Pathmanathan N; Shaban M; Raza SEA; Minhas F; Armes JE; Rajpoot N
    J Pathol; 2023 May; 260(1):32-42. PubMed ID: 36705810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
    Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
    J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence.
    Makhlouf S; Wahab N; Toss M; Ibrahim A; Lashen AG; Atallah NM; Ghannam S; Jahanifar M; Lu W; Graham S; Mongan NP; Bilal M; Bhalerao A; Snead D; Minhas F; Raza SEA; Rajpoot N; Rakha E
    Br J Cancer; 2023 Nov; 129(11):1747-1758. PubMed ID: 37777578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
    O'Loughlin M; Andreu X; Bianchi S; Chemielik E; Cordoba A; Cserni G; Figueiredo P; Floris G; Foschini MP; Heikkilä P; Kulka J; Liepniece-Karele I; Regitnig P; Reiner A; Ryska A; Sapino A; Shalaby A; Stovgaard ES; Quinn C; Walsh EM; Zolota V; Glynn SA; Callagy G
    Breast Cancer Res Treat; 2018 Aug; 171(1):1-9. PubMed ID: 29774470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies.
    Verghese G; Li M; Liu F; Lohan A; Kurian NC; Meena S; Gazinska P; Shah A; Oozeer A; Chan T; Opdam M; Linn S; Gillett C; Alberts E; Hardiman T; Jones S; Thavaraj S; Jones JL; Salgado R; Pinder SE; Rane S; Sethi A; Grigoriadis A
    J Pathol; 2023 Aug; 260(4):376-389. PubMed ID: 37230111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy.
    Park JH; Jonas SF; Bataillon G; Criscitiello C; Salgado R; Loi S; Viale G; Lee HJ; Dieci MV; Kim SB; Vincent-Salomon A; Curigliano G; André F; Michiels S
    Ann Oncol; 2019 Dec; 30(12):1941-1949. PubMed ID: 31566659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
    Matsumoto H; Thike AA; Li H; Yeong J; Koo SL; Dent RA; Tan PH; Iqbal J
    Breast Cancer Res Treat; 2016 Apr; 156(2):237-47. PubMed ID: 26960711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer.
    Pang J; Zhou H; Dong X; Wang S; Xiao Z
    Clin Breast Cancer; 2021 Dec; 21(6):e681-e687. PubMed ID: 34001439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
    Van Bockstal MR; François A; Altinay S; Arnould L; Balkenhol M; Broeckx G; Burguès O; Colpaert C; Dedeurwaerdere F; Dessauvagie B; Duwel V; Floris G; Fox S; Gerosa C; Hastir D; Jaffer S; Kurpershoek E; Lacroix-Triki M; Laka A; Lambein K; MacGrogan GM; Marchiò C; Martin Martinez MD; Nofech-Mozes S; Peeters D; Ravarino A; Reisenbichler E; Resetkova E; Sanati S; Schelfhout AM; Schelfhout V; Shaaban A; Sinke R; Stanciu-Pop CM; van Deurzen CHM; Van de Vijver KK; Van Rompuy AS; Vincent-Salomon A; Wen HY; Wong S; Bouzin C; Galant C
    Mod Pathol; 2021 Dec; 34(12):2130-2140. PubMed ID: 34218258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
    Candelaria RP; Spak DA; Rauch GM; Huo L; Bassett RL; Santiago L; Scoggins ME; Guirguis MS; Patel MM; Whitman GJ; Moulder SL; Thompson AM; Ravenberg EE; White JB; Abuhadra NK; Valero V; Litton J; Adrada BE; Yang WT
    Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S35-S41. PubMed ID: 34272161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated quantification of stromal tumour infiltrating lymphocytes is associated with prognosis in breast cancer.
    Gonzàlez-Farré M; Gibert J; Santiago-Díaz P; Santos J; García P; Massó J; Bellosillo B; Lloveras B; Albanell J; Vázquez I; Comerma L
    Virchows Arch; 2023 Nov; 483(5):655-663. PubMed ID: 37500796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
    Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P
    Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases.
    Fuchs TL; Pearson A; Pickett J; Diakos C; Dewar R; Chan D; Guminski A; Menzies A; Baron-Hay S; Sheen A; Sioson L; Chou A; Gill AJ
    Pathology; 2020 Aug; 52(5):515-521. PubMed ID: 32553444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.
    de Boo LW; Jóźwiak K; Ter Hoeve ND; van Diest PJ; Opdam M; Wang Y; Schmidt MK; de Jong V; Kleiterp S; Cornelissen S; Baars D; Koornstra RHT; Kerver ED; van Dalen T; Bins AD; Beeker A; van den Heiligenberg SM; de Jong PC; Bakker SD; Rietbroek RC; Konings IR; Blankenburgh R; Bijlsma RM; Imholz ALT; Stathonikos N; Vreuls W; Sanders J; Rosenberg EH; Koop EA; Varga Z; van Deurzen CHM; Mooyaart AL; Córdoba A; Groen E; Bart J; Willems SM; Zolota V; Wesseling J; Sapino A; Chmielik E; Ryska A; Broeks A; Voogd AC; van der Wall E; Siesling S; Salgado R; Dackus GMHE; Hauptmann M; Kok M; Linn SC
    ESMO Open; 2024 Mar; 9(3):102923. PubMed ID: 38452438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer.
    Fisher TB; Saini G; Rekha TS; Krishnamurthy J; Bhattarai S; Callagy G; Webber M; Janssen EAM; Kong J; Aneja R
    Breast Cancer Res; 2024 Jan; 26(1):12. PubMed ID: 38238771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers.
    Tian T; Ruan M; Yang W; Shui R
    Oncotarget; 2016 Jul; 7(28):44395-44405. PubMed ID: 27323808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer.
    Lee HJ; Park IA; Song IH; Shin SJ; Kim JY; Yu JH; Gong G
    J Clin Pathol; 2016 May; 69(5):422-30. PubMed ID: 26475777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the tumor immune microenvironment phenotypes in different breast cancers after neoadjuvant therapy.
    Han M; Li J; Wu S; Wu C; Yu Y; Liu Y
    Cancer Med; 2023 Feb; 12(3):2906-2917. PubMed ID: 36073303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome.
    Beckers RK; Selinger CI; Vilain R; Madore J; Wilmott JS; Harvey K; Holliday A; Cooper CL; Robbins E; Gillett D; Kennedy CW; Gluch L; Carmalt H; Mak C; Warrier S; Gee HE; Chan C; McLean A; Walker E; McNeil CM; Beith JM; Swarbrick A; Scolyer RA; O'Toole SA
    Histopathology; 2016 Jul; 69(1):25-34. PubMed ID: 26588661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.
    Loi S; Drubay D; Adams S; Pruneri G; Francis PA; Lacroix-Triki M; Joensuu H; Dieci MV; Badve S; Demaria S; Gray R; Munzone E; Lemonnier J; Sotiriou C; Piccart MJ; Kellokumpu-Lehtinen PL; Vingiani A; Gray K; Andre F; Denkert C; Salgado R; Michiels S
    J Clin Oncol; 2019 Mar; 37(7):559-569. PubMed ID: 30650045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.